Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2019

Jan 10, 2020

SELL
$3.46 - $6.93 $17 - $34
-5 Closed
0 $0
Q1 2019

Apr 17, 2019

SELL
$7.08 - $12.09 $70 - $120
-10 Reduced 66.67%
5 $0
Q4 2018

Jan 22, 2019

BUY
$8.14 - $13.28 $40 - $66
5 Added 50.0%
15 $0
Q2 2018

Jul 18, 2018

BUY
$15.15 - $20.75 $151 - $207
10 New
10 $0

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.74B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.